
Personalized mRNA vaccines will revolutionize cancer treatment—if funding cuts don’t doom them
Vaccines based on mRNA can be tailored to target a cancer patient’s unique tumor mutations. But crumbling support for cancer and mRNA vaccine research has endangered this promising therapy

